Biocon Biologics gets DCGI approval for emergency use of CytoSorb to treat critical COVID-19 patients Read more
US pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India Read more
DCGI approves Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease Read more